RXD vs. CURE
RXD (ProShares UltraShort Health Care) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both Leveraged Equities funds - RXD tracks the DJ Global United States (All) / Health Care -IND (-200%) while CURE tracks the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, RXD returned -19.63%/yr vs 13.35%/yr for CURE. Their -0.86 correlation means they have often moved in opposite directions in the past. RXD charges 0.95%/yr vs 0.94%/yr for CURE.
Performance
RXD vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RXD achieves a -10.24% return, which is significantly lower than CURE's 6.99% return. Over the past 10 years, RXD has underperformed CURE with an annualized return of -19.63%, while CURE has yielded a comparatively higher 13.35% annualized return.
RXD
- 1D
- 0.47%
- 1M
- 0.46%
- 6M
- -10.79%
- YTD
- -10.24%
- 1Y
- -35.49%
- 3Y*
- -10.24%
- 5Y*
- -7.59%
- 10Y*
- -19.63%
- ALL TIME*
- -22.75%
CURE
- 1D
- -1.72%
- 1M
- -3.56%
- 6M
- 9.07%
- YTD
- 6.99%
- 1Y
- 68.66%
- 3Y*
- 7.13%
- 5Y*
- 0.86%
- 10Y*
- 13.35%
- ALL TIME*
- 24.24%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $8.40M | $9.61M | $9.25M | |
| $208.34K | $158.30K | $97.64K |
RXD vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | -10.24% | -21.66% | 4.83% | 3.25% | 1.20% | -37.97% | -44.25% | -32.44% | -14.33% | -35.24% |
CURE Direxion Daily Healthcare Bull 3x Shares | 6.99% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between RXD and CURE is -0.99, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.99 |
Correlation (3Y) Balances recent behavior with more history. | -0.99 |
Correlation (5Y) Shows whether the relationship held over a longer period. | -0.99 |
Correlation (10Y) Provides a long-term view across more market conditions. | -0.91 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | -0.86 |
The correlation between RXD and CURE shifts across timeframes, from -0.99 (1 year) to -0.86 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RXD vs. CURE — Risk / Return Rank
RXD
CURE
RXD vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RXD | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.73 | ||
| Sortino ratioReturn per unit of downside risk | -3.94 | ||
| Omega ratioGain probability vs. loss probability | 0.81 | 1.26 | -0.45 |
| Calmar ratioReturn relative to maximum drawdown | -0.89 | 2.31 | -3.20 |
| Martin ratioReturn relative to average drawdown | -1.40 | 5.20 | -6.60 |
Loading charts...
Drawdowns
RXD vs. CURE - Drawdown Comparison
The maximum RXD drawdown since its inception was -99.68%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for RXD and CURE.
Loading charts...
Drawdown Indicators
| RXD | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.68% | -69.19% | -30.49% |
Max Drawdown (1Y)Largest decline over 1 year | -40.79% | -31.10% | -9.69% |
Max Drawdown (3Y)Largest decline over 3 years | -42.58% | -51.93% | +9.35% |
Max Drawdown (5Y)Largest decline over 5 years | -46.11% | -52.23% | +6.12% |
Max Drawdown (10Y)Largest decline over 10 years | -91.52% | -69.19% | -22.33% |
Current DrawdownCurrent decline from peak | -99.67% | -15.08% | -84.59% |
Average DrawdownAverage peak-to-trough decline | -82.00% | -18.17% | -63.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.78% | 13.82% | +11.96% |
Volatility
RXD vs. CURE - Volatility Comparison
The current volatility for ProShares UltraShort Health Care (RXD) is 11.80%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 17.62%. This indicates that RXD experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RXD | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.80% | 17.62% | -5.82% |
Volatility (6M)Calculated over the trailing 6-month period | 24.09% | 35.23% | -11.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.60% | 46.92% | -15.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.35% | 44.69% | -14.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.15% | 49.85% | -16.70% |
RXD vs. CURE - Expense Ratio Comparison
RXD has a 0.95% expense ratio, which is higher than CURE's 0.94% expense ratio.
Dividends
RXD vs. CURE - Dividend Comparison
RXD's dividend yield for the trailing twelve months is around 3.31%, more than CURE's 1.06% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.06% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
RXD ProShares UltraShort Health Care | 3.31% | 3.29% | 4.36% | 3.17% | 0.67% | 0.00% | 0.17% | 1.73% | 0.22% | 0.00% |
Frequently Asked Questions
RXD and CURE have a correlation of -0.99, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (17.62%) compared to RXD (11.80%). In terms of maximum drawdown, RXD dropped -99.68% vs CURE's -69.19%.
On 10-year performance, CURE leads with 13.35% vs -19.63% for RXD. On fees, CURE is cheaper at 0.94% per year. On volatility, RXD has been the lower-risk option at 11.80%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.35% return vs -19.63%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CURE is cheaper with a 0.94% expense ratio, compared with 0.95% for RXD.
RXD has the higher dividend yield at 3.31%, compared with 1.06% for CURE.
RXD tracks DJ Global United States (All) / Health Care -IND (-200%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for RXD and 0.94% for CURE.
CURE currently has the higher Sharpe Ratio (1.56 vs -1.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RXD and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer